428 filings
10-Q
2024 Q1
HEPA
Hepion Pharmaceuticals Inc
Quarterly report
21 May 24
5:08pm
NT 10-Q
HEPA
Hepion Pharmaceuticals Inc
15 May 24
Notice of late quarterly filing
4:46pm
10-K
2023 FY
HEPA
Hepion Pharmaceuticals Inc
Annual report
16 Apr 24
4:53pm
NT 10-K
HEPA
Hepion Pharmaceuticals Inc
1 Apr 24
Notice of late annual filing
4:30pm
8-K
HEPA
Hepion Pharmaceuticals Inc
6 Mar 24
Departure of Directors or Certain Officers
4:15pm
8-K
24c1hri96san3myaeqy
20 Feb 24
Departure of Directors or Certain Officers
4:15pm
8-K
2b3llhj
16 Feb 24
Entry into a Material Definitive Agreement
9:02am
8-K
hj0bsu r72ofo
7 Feb 24
Departure of Directors or Certain Officers
4:15pm
8-K
0bzja8b03 kk1lfwq5
3 Jan 24
Changes in Registrant's Certifying Accountant
4:30pm
8-K
q57bw
7 Dec 23
Hepion Pharmaceuticals Announces Restructuring Plan to Enhance Shareholder Value and Management Changes
8:41am
NT 10-Q
7z2a0bbhw53bfswl
14 Nov 23
Notice of late quarterly filing
4:46pm
EFFECT
8cizpkcb deo3bus3m8
9 Nov 23
Notice of effectiveness
12:15am
CORRESP
vpsyp6hch gzx8lt
6 Nov 23
Correspondence with SEC
12:00am
UPLOAD
fa5yyrekwch9xah2nk
3 Nov 23
Letter from SEC
12:00am
D
70s rugqcys97
3 Oct 23
$5.00 mm in equity / options, sold $5.00 mm, 1 investor
5:22pm
8-K
k9u gr7qdsi
2 Oct 23
Hepion Pharmaceuticals Announces $5.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under Nasdaq Rules
6:29pm
424B5
l6pr3rwvd ua
2 Oct 23
Prospectus supplement for primary offering
4:52pm
8-K
o8reegw1r9dfh9udi
6 Sep 23
Departure of Directors or Certain Officers
4:40pm